AML1-ETO fusion gene can not only be regarded as a molecular marker of acute myelocytic leukemia subtype M2b, but also is helpful in evaluating prognosis and monitoring remant leukemia.

• AML1-ETO融合基因可作为M2b亚型的分子标志物,同时对判断预后和监测残留白血病等方面也有一定价值。